Open Access

Upregulation of circ‑ASPH contributes to glioma cell proliferation and aggressiveness by targeting the miR‑599/AR/SOCS2‑AS1 signaling pathway

  • Authors:
    • Yi Qu
    • Li Qi
    • Liguo Hao
    • Jian Zhu
  • View Affiliations

  • Published online on: March 17, 2021     https://doi.org/10.3892/ol.2021.12649
  • Article Number: 388
  • Copyright: © Qu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioma (GM) is the most common type of malignant brain tumor with a high recurrence rate. Circular RNAs (circRNAs) play a key role in mediating tumorigenesis. However, the functions and mechanisms of circRNAs in GM are still not fully understood. A circRNA microarray was performed to identify differentially expressed circRNAs in GM and non‑cancerous specimens. Reverse transcription‑quantitative PCR was used to detect circ‑aspartyl/asparaginyl β‑hydroxylase (ASPH) expression in GM tissues and cells. The clinical importance of circ‑ASPH was investigated using Kaplan‑Meier analysis. The functions of circ‑ASPH were investigated in LN229 and U87MG cells. Bioinformatics, RNA immunoprecipitation, RNA pull‑down and luciferase reporter assays were used to explore the mechanisms of circ‑ASPH in GM. circ‑ASPH levels were upregulated in GM specimens and cells. The prognostic role of circ‑ASPH was identified in patients with GM. Loss/gain of function assays demonstrated that circ‑ASPH increased cell proliferation, migration and invasion in GM cells. Mechanistically, circ‑ASPH counteracted microRNA (miR)‑599‑mediated androgen receptor (AR) suppression by acting as a sponge for miR‑599. Rescue assays indicated that circ‑ASPH facilitated cell progression by regulating AR expression. Moreover, AR activated long non‑coding RNA suppressor of cytokine signaling 2‑antisense RNA 1 (SOCS2‑AS1) expression in GM cells. Taken together, circ‑ASPH/miR‑599/AR/SOCS2‑AS1 signaling may be a promising biomarker/therapeutic target for GM.
View Figures
View References

Related Articles

Journal Cover

May-2021
Volume 21 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qu Y, Qi L, Hao L and Zhu J: Upregulation of circ‑ASPH contributes to glioma cell proliferation and aggressiveness by targeting the miR‑599/AR/SOCS2‑AS1 signaling pathway. Oncol Lett 21: 388, 2021.
APA
Qu, Y., Qi, L., Hao, L., & Zhu, J. (2021). Upregulation of circ‑ASPH contributes to glioma cell proliferation and aggressiveness by targeting the miR‑599/AR/SOCS2‑AS1 signaling pathway. Oncology Letters, 21, 388. https://doi.org/10.3892/ol.2021.12649
MLA
Qu, Y., Qi, L., Hao, L., Zhu, J."Upregulation of circ‑ASPH contributes to glioma cell proliferation and aggressiveness by targeting the miR‑599/AR/SOCS2‑AS1 signaling pathway". Oncology Letters 21.5 (2021): 388.
Chicago
Qu, Y., Qi, L., Hao, L., Zhu, J."Upregulation of circ‑ASPH contributes to glioma cell proliferation and aggressiveness by targeting the miR‑599/AR/SOCS2‑AS1 signaling pathway". Oncology Letters 21, no. 5 (2021): 388. https://doi.org/10.3892/ol.2021.12649